Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Codexis Inc. | 7 | 2 | 0 | 0 | €2.74 | €8.36 | 205.380% |
| Verastem Inc. | 10 | 0 | 0 | 0 | €2.52 | €19.20 | 661.901% |
| Enanta Pharmaceuticals Inc. | 6 | 4 | 0 | 0 | €12.00 | €25.58 | 113.150% |
| Rockwell Medical Inc. | 1 | 0 | 0 | 0 | €1.60 | €3.00 | 87.852% |
| MacroGenics Inc. | 13 | 0 | 0 | 0 | €3.89 | €12.42 | 219.401% |
| TG Therapeutics Inc. | 22 | 3 | 0 | 0 | €17.53 | €28.06 | 60.131% |
| Radnet Inc. | 9 | 3 | 0 | 0 | €55.50 | €54.58 | -1.657% |
| Pro-Dex Inc. | 12 | 0 | 0 | 0 | €15.20 | - | - |
| Intra-Cellular Therapies Inc. | 34 | 0 | 9 | 0 | €64.50 | €84.35 | 30.772% |
| Phibro Animal Health Corp. A | 3 | 2 | 0 | 0 | €15.70 | €12.06 | -23.159% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €2.97 | - | - |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.81 | €8.35 | 360.971% |
| Ocular Therapeutix Inc. | 17 | 4 | 8 | 0 | €6.20 | €12.21 | 97.036% |
| Adverum Biotechnologies Inc. | 8 | 0 | 1 | 0 | €1.38 | €13.07 | 847.449% |
| Abeona Therapeutics Inc. | 5 | 1 | 1 | 0 | €4.02 | €26.52 | 559.677% |
| Viking Therapeutics Inc | 7 | 0 | 2 | 0 | €47.27 | €62.50 | 32.219% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €73.34 | €80.00 | 9.081% |
| ImmunityBio Inc. | 2 | 0 | 0 | 0 | €5.86 | €10.00 | 70.590% |
| Lemaitre Vascular Inc | 2 | 0 | 0 | 0 | €74.50 | €73.50 | -1.342% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €46.00 | €50.00 | 8.696% |
| Aclaris Therapeutics Inc | 4 | 0 | 3 | 0 | €1.09 | €2.75 | 153.456% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €75.64 | €100.00 | 32.205% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €1.59 | €6.45 | 304.806% |
| Chromadex Corp | 10 | 1 | 1 | 0 | €2.42 | €5.55 | 129.488% |
| Syros Pharmaceuticals Inc. | 8 | 1 | 2 | 0 | €4.68 | €13.60 | 190.545% |